Jonathan Richard Symonds is a British businessperson who founded Oxford University Centre for Business Taxation and who has been at the head of 8 different companies. Presently, Mr. Symonds is Non-Executive Chairman of GlaxoSmithKline Plc and Chairman of Proteus Digital Health, Inc. Mr. Symonds is also on the board of Genomics England Ltd. (former Chairman), Rubius Therapeutics, Inc. and Harrow School and Head-Corporate Finance & Strategy at Mesoblast Ltd.

Jonathan Richard Symonds previously occupied the position of Chairman at The 100 Group, Chairman-Supervisory Board for Innocoll Holdings Plc Chairman for Innocoll, Inc. and Chairman-Supervisory Board at Innocoll AG (both are subsidiaries of Innocoll Holdings Plc), Chief Financial Officer at AstraZeneca Plc and Director-Finance at Zeneca Group Plc (a subsidiary of AstraZeneca Plc), Chief Financial Officer at Novartis AG, Managing Director at The Goldman Sachs Group, Inc., Director at Accounting Standards Board, Chairman of HSBC Bank Plc and Partner at KPMG LLP (Canada).

Jonathan Richard Symonds received an undergraduate degree from the University of Hertfordshire.